These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 31799361)

  • 41. Studies on the neutralizing effects of protamine on unfractionated and low molecular weight heparin (Fragmin) at the site of activation of the coagulation system in man.
    Wolzt M; Weltermann A; Nieszpaur-Los M; Schneider B; Fassolt A; Lechner K; Eichler HG; Kyrle PA
    Thromb Haemost; 1995 Mar; 73(3):439-43. PubMed ID: 7667826
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of Centrifuge Temperature on Routine Coagulation Tests.
    Yazar H; Özdemir F; Köse E
    Acta Haematol; 2018; 139(3):158-163. PubMed ID: 29550825
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Activated partial thromboplastin time versus antifactor Xa heparin assay in monitoring unfractionated heparin by continuous intravenous infusion.
    Guervil DJ; Rosenberg AF; Winterstein AG; Harris NS; Johns TE; Zumberg MS
    Ann Pharmacother; 2011 Jul; 45(7-8):861-8. PubMed ID: 21712506
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of a chromogenic assay to measure the factor Xa inhibitory activity of unfractionated heparin in canine plasma.
    Brooks MB
    Vet Clin Pathol; 2004; 33(4):208-14. PubMed ID: 15570557
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of factor VIII levels on the APTT and anti-Xa activity under a therapeutic dose of heparin.
    Mitsuguro M; Okamoto A; Shironouchi Y; Sano M; Miyata S; Neki R; Araki T; Hamamoto T; Yoshimatsu J; Miyata T
    Int J Hematol; 2015 Feb; 101(2):119-25. PubMed ID: 25416968
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Agreement between activated partial thromboplastin time and anti-Xa activity in critically ill patients receiving therapeutic unfractionated heparin.
    Ratano D; Alberio L; Delodder F; Faouzi M; Berger MM
    Thromb Res; 2019 Mar; 175():53-58. PubMed ID: 30708169
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparability of the results of PT-INR with local MNPT and APTTR with MNAPTT on different coagulation analyzers in China.
    Peng L; Yan C; Wu X; Nie L
    Int J Lab Hematol; 2009 Jun; 31(3):352-8. PubMed ID: 18510575
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of the automated coagulation analyzer Sysmex CA-7000.
    Dorn-Beineke A; Dempfle CE; Bertsch T; Wisser H
    Thromb Res; 2005; 116(2):171-9. PubMed ID: 15907533
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pre-analytical practices for routine coagulation tests in European laboratories. A collaborative study from the European Organisation for External Quality Assurance Providers in Laboratory Medicine (EQALM).
    Kristoffersen AH; Stavelin AV; Ajzner E; Kristensen GBB; Sandberg S; Van Blerk M; Kitchen S; Kesseler D; Woods TAL; Meijer P
    Clin Chem Lab Med; 2019 Sep; 57(10):1511-1521. PubMed ID: 31085743
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Thrombin formation and effect of unfractionated heparin during pediatric cardiac catheterization.
    Chen D; Långström S; Petäjä J; Heikinheimo M; Pihkala J
    Catheter Cardiovasc Interv; 2013 Jun; 81(7):1174-9. PubMed ID: 22915548
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation and performance characteristics of the Q Hemostasis Analyzer, an automated coagulation analyzer.
    Toulon P; Fischer F; Appert-Flory A; Jambou D
    Thromb Res; 2014 May; 133(5):927-35. PubMed ID: 24650798
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antifactor Xa levels vs. activated partial thromboplastin time for monitoring unfractionated heparin. A pilot study.
    Samuel S; Allison TA; Sharaf S; Yau G; Ranjbar G; Mckaig N; Nguyen A; Escobar M; Choi HA
    J Clin Pharm Ther; 2016 Oct; 41(5):499-502. PubMed ID: 27381025
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Confounding effect of therapeutic protamine and heparin levels on routine and special coagulation testing.
    Khandelwal A; Phua CW; Chaudhry HR; Tsui H; Rivard GE; Teitel JM; Sholzberg M
    Blood Coagul Fibrinolysis; 2020 Jan; 31(1):60-64. PubMed ID: 31904611
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of unfractionated heparin protocols using antifactor Xa monitoring or activated partial thrombin time monitoring.
    Frugé KS; Lee YR
    Am J Health Syst Pharm; 2015 Sep; 72(17 Suppl 2):S90-7. PubMed ID: 26272899
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Can an anti-Xa assay for unfractionated heparin be used to assess the presence of rivaroxaban in critical situations?
    Shin H; Koh EH; Lee GW; Song HN; Kim HY; Park S
    J Vasc Surg Venous Lymphat Disord; 2020 Sep; 8(5):741-747. PubMed ID: 32113855
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparative analysis of platelet depleted plasma prepared on the Roche 8100 automation line and manually centrifuged platelet poor plasma for routine coagulation assays.
    Barbhuiya MA; Livingston R; Baranoski S; Creer MH; Oladipo O
    Pract Lab Med; 2023 Aug; 36():e00324. PubMed ID: 37649543
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effects of unfractionated heparin, low molecular weight heparin and danaparoid on the thromboelastogram (TEG): an in-vitro comparison of standard and heparinase-modified TEGs with conventional coagulation assays.
    Coppell JA; Thalheimer U; Zambruni A; Triantos CK; Riddell AF; Burroughs AK; Perry DJ
    Blood Coagul Fibrinolysis; 2006 Mar; 17(2):97-104. PubMed ID: 16479191
    [TBL] [Abstract][Full Text] [Related]  

  • 58. How to Optimize Activated Partial Thromboplastin Time (APTT) Testing: Solutions to Establishing and Verifying Normal Reference Intervals and Assessing APTT Reagents for Sensitivity to Heparin, Lupus Anticoagulant, and Clotting Factors.
    Favaloro EJ; Kershaw G; Mohammed S; Lippi G
    Semin Thromb Hemost; 2019 Feb; 45(1):22-35. PubMed ID: 30630206
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Monitoring unfractionated heparin in children: a parallel-cohort randomized controlled trial comparing 2 dose protocols.
    Hanslik A; Kitzmüller E; Tran US; Thom K; Karapetian H; Prutsch N; Voitl J; Michel-Behnke I; Newall F; Male C
    Blood; 2015 Oct; 126(18):2091-7. PubMed ID: 26239090
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Canine reference intervals for coagulation markers using the STA Satellite(R) and the STA-R Evolution(R) analyzers.
    Geffré A; Grollier S; Hanot C; Vergez F; Trumel C; Braun JP
    J Vet Diagn Invest; 2010 Sep; 22(5):690-5. PubMed ID: 20807922
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.